Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786149 · ClinicalTrials.gov registry record · Phase 3
Improving Varenicline Adherence and Outcomes in Homeless Smokers
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 428
- Enrollment target
NCT00786149: Completed Phase 3 study, sponsored by University of Minnesota.
NCT00786149 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 428 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786149, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 428 participants
- Enrollment target
Study Summary
the purpose of the study is to see if varenicline in combination with motivational counseling helps homeless cigarette smokers quit smoking.
Interventions
- OTHER Varenicline plus Motivational Interviewing counseling
- OTHER Varenicline without counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
What the finished NCT00786149 record still lists
NCT00786149 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Varenicline plus Motivational Interviewing counseling is the first listed.
NCT00786149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00786149 about?
NCT00786149 is a clinical study titled "Improving Varenicline Adherence and Outcomes in Homeless Smokers". the purpose of the study is to see if varenicline in combination with motivational counseling helps homeless cigarette smokers quit smoking.
What is the current status of trial NCT00786149?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 428 participants. The study started on 2007-09. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00786149?
The interventions under investigation include: Varenicline plus Motivational Interviewing counseling (OTHER), Varenicline without counseling (OTHER).
Who is sponsoring clinical trial NCT00786149?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00786149's enrollment target sits among peer trials
428 878th of 2000 higher than 1,121 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia